SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-044825
Filing Date
2023-04-13
Accepted
2023-04-13 08:00:53
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231869d4_def14a.htm   iXBRL DEF 14A 2109162
6 GRAPHIC bc_capvsnetinc-4c.jpg GRAPHIC 127579
7 GRAPHIC bc_capvstsr-4c.jpg GRAPHIC 190665
8 GRAPHIC bc_ceo-4c.jpg GRAPHIC 112075
9 GRAPHIC lc_performance-4c.jpg GRAPHIC 265102
10 GRAPHIC lg_adaptimmunetrfm-4clr.jpg GRAPHIC 49306
11 GRAPHIC pc_ceo-bw.jpg GRAPHIC 35194
12 GRAPHIC pc_oneo-bw.jpg GRAPHIC 35112
13 GRAPHIC px_01proxy-bw.jpg GRAPHIC 1218042
14 GRAPHIC px_02proxy-bw.jpg GRAPHIC 822746
  Complete submission text file 0001104659-23-044825.txt   10305189

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adap-20221231.xsd EX-101.SCH 9125
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adap-20221231_def.xml EX-101.DEF 7358
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20221231_lab.xml EX-101.LAB 23084
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20221231_pre.xml EX-101.PRE 10836
17 EXTRACTED XBRL INSTANCE DOCUMENT tm231869d4_def14a_htm.xml XML 274535
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37368 | Film No.: 23817083
SIC: 2836 Biological Products, (No Diagnostic Substances)